Phase I dose escalation trial of biweekly Altima [pemetrexed] (with vitamin supplementation) in combination with taxotere [docetaxel] in advanced solid tumor patients

Trial Profile

Phase I dose escalation trial of biweekly Altima [pemetrexed] (with vitamin supplementation) in combination with taxotere [docetaxel] in advanced solid tumor patients

Not stated
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2006

At a glance

  • Drugs Pemetrexed (Primary) ; Docetaxel
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Jun 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top